Hypoglycemic effect enhancer
AssigneeBiofermin Pharmaceutical Co., Ltd.
InventorsYasuhiro Isa, Masaki Shimakawa, Hiroshi Ohno, Hideki Yamamura
Life of this patent
Estimating the term…
Abstract
A hypoglycemic effect enhancer for enhancing the activity of an α-glucosidase inhibitor, the enhancer comprising at least one kind of bacteria selected from the group consisting of bifidobacteria, lactic acid bacteria, saccharifying bacteria, and butyric acid bacteria.
Claims3
A method for enhancing the hypoglycemic activity of voglibose, the method comprising administering to a patient in need thereof lactic acid bacteria, and saccharifying bacteria or bifidobacteria in combination with voglibose, and enhancing the hypoglycemic activity of voglibose.
A method for enhancing the hypoglycemic activity of lactic acid bacteria, and saccharifying bacteria or bifidobacteria, the method comprising administering to a patient in need thereof voglibose in combination with the bacteria, and enhancing the hypoglycemic activity of the bacteria.
A method for promoting the expression of the hypoglycemic activity of voglibose, the method comprising administering to a patient in need thereof lactic acid bacteria, and saccharifying bacteria or bifidobacteria in combination with voglibose, and promoting the expression of the hypoglycemic activity of voglibose.
Dependencies are inferred from the claim text.